In vitro inhibitory effects of some acetophenone derivatives on some metabolic enzymes and molecular docking
Corresponding Author
Parham Taslimi
Department of Biotechnology, Faculty of Science, Bartin University, Bartin, Turkey
Correspondence Parham Taslimi, Department of Biotechnology, Faculty of Science, Bartin University, 74100 Bartin, Turkey.
Email: [email protected] and [email protected]
Search for more papers by this authorCorresponding Author
Parham Taslimi
Department of Biotechnology, Faculty of Science, Bartin University, Bartin, Turkey
Correspondence Parham Taslimi, Department of Biotechnology, Faculty of Science, Bartin University, 74100 Bartin, Turkey.
Email: [email protected] and [email protected]
Search for more papers by this authorAbstract
In this study, the acetophenone derivatives 1–6 were found to be effective inhibitor molecules for α-glycosidase, human carbonic anhydrases I and II (hCA I/II), and acetylcholinesterase (AChE), with Ki values in the range of 167.98 ± 25.06 to 304.36 ± 65.45 µM for α-glycosidase, 555.76 ± 56.07 to 1,043.66 ± 98.78 µM for hCA I, 598.63 ± 90.04 to 945.76 ± 74.50 µM for hCA II, and 71.34 ± 11.25 to 143.75 ± 31.27 µM for AChE, and IC50 values of 73.65–101.13 µM for tyrosinase. In the last step, molecular docking calculations were performed to compare the biological activities of molecules with their docking scores in these enzymes. The interactions of the studied molecules against human α-galactosidase (PDB ID: 1R47), hCA I (PDB ID: 3LXE), human AChE (PDB ID: 4M0E), hCA II (PDB ID: 5AML), and human tyrosinase (PDB ID: 5M8Q) were examined to compare the biological activity values. The ADME/T analysis (adsorption, distribution, metabolism, and discharge) was then performed for the future use of these molecules as drugs.
Supporting Information
Filename | Description |
---|---|
ardp202000210-sup-0001-InChI_keys.docx38.2 KB | Supporting information |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1R. Guo, X. Chen., C. Elphelt, D. Song, R. H. Morris, Org. Lett. 2005, 7, 9.
- 2P. Pelagatti, M. Carcelli, F. Calbiani, C. Cassi, L. Elviri, C. Pelizzi, U. Rizzotti, D. Rogolino, Organometallics 2005, 24, 5836.
- 3J. W. Faller, A. R. Lavoie, Organometallics 2001, 20, 5245.
- 4İ. Gülçin, A. Z. Tel, A. C. Gören, P. Taslimi, S. Alwasel, J. Food Meas. Charact. 2019, 13, 2062.
- 5P. Taslimi, F. M. Kandemir, Y. Demir, M. İleritürk, Y. Temel, C. Cağlayan, İ. Gülçin, J. Biochem. Mol. Toxicol. 2019, 33, e22313.
- 6H. Genc Bilgicli, A. Kestane, P. Taslimi, O. Karabay, A. Bytyqi-Damoni, M. Zengin, İ. Gulçin, Bioorg. Chem. 2019, 88, 102931.
- 7F. Türkan, A. Çetin, P. Taslimi, H. S. Karaman, İ. Gulçin, Arch. Pharm. 2019, 352, e1800359.
- 8M. Boztas, P. Taslimi, M. A. Yavari, İ. Gülçin, E. Sahin, A. Menzek, Bioorg. Chem. 2019, 89, 103017.
- 9U. M. Koçyiğit, Y. Budak, M. B. Gürdere, N. Dürü, P. Taslimi, İ. Gulçin, M. Ceylan, Monatsh. Chem. 2019, 150, 721.
- 10A. Cetin, F. Turkan, P. Taslimi, İ. Gulçin, J. Biochem. Mol. Toxicol. 2019, 33, e22261.
- 11K. Küçükoğlu, H. İ. Gül, P. Taslimi, İ. Gülçin, C. T. Supuran, Bioorg. Chem. 2019, 86, 316.
- 12A. Maharramov, R. Kaya, P. Taslimi, M. Kurbanova, A. Sadigova, V. Farzaliyev, A. Sujayev, İ. Gulçin, Arch. Pharm. 2019, 352, e1800317.
- 13M. Takahashi, K. Takara, T. Toyozato, K. Wada, J. Oleo Sci. 2012, 61, 585.
- 14X. Zhang, X. Hu, A. Hou, H. Wang, Biol. Pharm. Bull. 2009, 32, 86.
- 15A. Bytyqi-Damoni, A. Kestane, P. Taslimi, B. Tuzun, M. Zengin, H. G. Bilgicli, İ. Gulcin, J. Mol. Struct. 2020, 1202, 127297.
- 16B. Tüzün, S. Çağlar Yavuz, E. Sarıpınar, J. Phys. Chem. 2018, 14, 149.
- 17B. Tüzün, E. Saripinar, J. Iran. Chem. Soc. 2019, 17, 985.
- 18S. C. Garman, D. N. Garboczi, J. Mol. Biol. 2004, 337, 319.
- 19V. Alterio, S. M. Monti, E. Truppo, C. Pedone, C. T. Supuran, G. De Simone, Org. Biomol. Chem. 2010, 8, 3528.
- 20J. Cheung, E. N. Gary, K. Shiomi, T. L. Rosenberry, ACS Med. Chem. Lett. 2013, 4, 1091.
- 21J. Ivanova, J. Leitans, M. Tanc, A. Kazaks, R. Zalubovskis, C. T. Supuran, K. Tars, Chem. Commun. 2015, 51, 7108.
- 22X. Lai, H. J. Wichers, M. Soler-Lopez, B. W. Dijkstra, Angew. Chem., Int. Ed. 2017, 56, 9812.
- 23A. Biçer, P. Taslimi, G. Yakalı, İ. Gülcin, M. S. Gültekin, G. T. Cin, Bioorg. Chem. 2019, 82, 393.
- 24M. Huseynova, A. Medjidov, P. Taslimi, M. Aliyeva, Bioorg. Chem. 2019, 83, 55.
- 25S. Daryadel, U. Atmaca, P. Taslimi, İ. Gülçin, M. Çelik, Arch. Pharm. 2018, 351, e1800209.
- 26M. Huseynova, P. Taslimi, A. Medjidov, V. Farzaliyev, M. Aliyeva, G. Gondolova, O. Şahin, B. Yalçın, A. Sujayev, E. B. Orman, A. R. Özkaya, İ. Gülçin, Polyhedron 2018, 155, 25.
- 27G. Zengin, A. Stefanucci, M. J. Rodrigues, A. Mollica, L. Custodio, M. Z. Aumeeruddy, M. F. Mahomoodally, J. Pharm. Biomed. Anal. 2019, 162, 225.
- 28A. Uysal, O. Y. Ozer, G. Zengin, A. Stefanucci, A. Mollica, C. M. N. Picot-Allain, M. F. Mahomoodally, Comput. Biol. Chem. 2019, 78, 64.
- 29Z. Özdemir, S. Sari, A. Karakurt, S. Dalkara, Drug Dev. Res. 2019, 80, 269.
- 30Y. Dundar, O. Kuyrukcu, G. Eren, F. S. S. Deniz, T. Onkol, I. E. Orhan, Bioorg. Chem. 2019, 92, 103304.
- 31Z. Alım, D. Kılıç, Y. Demir, Arch. Physiol. Biochem. 2019, 125, 387.
- 32F. Trampetti, C. Pereira, M. J. Rodrigues, O. Celaj, B. D'Abrosca, G. Zengin, A. Mollica Stefanucci, L. Custódio, J. Pharm. Biomed. Anal. 2019, 165, 119.
- 33K. Sayin, A. Üngördü, Spectrochim. Acta, Part A 2019, 220, 117102.
- 34K. Sayin, D. Karakaş, Spectrochim. Acta, Part A 2018, 202, 276.
- 35K. Sayin, D. Karakaş, J. Mol. Struct. 2018, 1158, 57.
- 36K. Sayin, A. Üngördü, Spectrochim. Acta, Part A 2018, 193, 147.
- 37K. Sayin, D. Karakaş, J. Mol. Struct. 2017, 1146, 191.
- 38R. Jayarajan, R. Satheeshkumar, T. Kottha, S. Subbaramanian, K. Sayin, G. Vasuki, Spectrochim. Acta, Part A 2020, 229, 117861.
- 39A. Üngördü, K. Sayin, Chem. Phys. Lett. 2019, 733, 136677.
- 40B. Tüzün, Spectrochim. Acta A Mol. Biomol. Spectrosc. 2020, 227, 117663.
- 41B. N. Sağlık, B. K. Çavuşoğlu, D. Osmaniye, S. Levent, U. A. Çevik, S. Ilgın, Y. Özkay, Z. A. Kaplancıklı, Y. Öztürk, Bioorg. Chem. 2019, 85, 97.
- 42B. N. Sağlık, U. A. Çevik, D. Osmaniye, S. Levent, B. K. Çavuşoğlu, Y. Demir, S. Ilgın, Y. Özkay, A. S. Koparal, Ş. Beydemir, Z. A. Kaplancıklı, Bioorg. Chem. 2019, 91, 103153.
- 43M. F. Acar, S. Sari, S. Dalkara, Drug Dev. Res. 2019, 80, 606.
- 44E. Menteşe, M. Emirik, B. B. Sökmen, Bioorg. Chem. 2019, 86, 151.
- 45P. Taslimi, Y. Erden, S. Mamedov, L. Zeynalova, N. Ladokhina, R. Tas, I. Gulcin, J. Biomol. Struct. Dyn. 2020, 1. Accepted. https://doi.org/10.1080/07391102.2020.1763838
- 46J. A. Verpoorte, S. Mehta, J. T. Edsall, J. Biol. Chem. 1967, 242, 4221.
- 47E. Güzel, U. M. Koçyiğit, B. S. Arslan, M. Ataş, P. Taslimi, F. Gökalp, M. Nebioğlu, İ. Şişman, İ. Gulçin, Arch. Pharm. 2019, 352, e1800292.
- 48B. Kuzu, M. Tan, P. Taslimi, İ. Gülçin, M. Taspınar, N. Menges, Bioorg. Chem. 2019, 86, 187.
- 49H. Lineweaver, D. Burk, J. Am. Chem. Soc. 1934, 56, 658.
- 50M. M. Bradford, Anal. Biochem. 1976, 72, 248.
- 51N. Eruygur, M. Ataş, M. Tekin, P. Taslimi, U. M. Koçyiğit, İ. Gulçin, S. Afr. J. Bot. 2019, 120, 141.
- 52G. L. Ellman, K. D. Courtney, V. Andres, R. M. Featherston, Biochem. Pharmacol. 1961, 7, 88.
- 53Ç. Bayrak, P. Taslimi, H. S. Kahraman, İ. Gülçin, A. Menzek, Bioorg. Chem. 2019, 85, 128.
- 54B. Yiğit, R. Kaya, P. Taslimi, Y. Işık, M. Karaman, M. Yiğit, İ. Özdemir, İ. Gulçin, J. Mol. Struct. 2019, 1179, 709.
- 55Y. Tao, Y. Zhang, Y. Cheng, Y. Wang, Biomed. Chromatogr. 2013, 27, 148.
- 56Y. Demir, P. Taslimi, M. S. Özaslan, N. Oztaskin, Y. Çetinkaya, İ. Gulçin, Ş. Beydemir, S. Goksu, Arch. Pharm. 2018, 351, e1800263.
- 57B. Tüzün, C. Kaya, J. Bio-Tribo-Corros. 2018, 4, 69.
10.1007/s40735-018-0185-5 Google Scholar
- 58A. Günsel, A. T. Bilgicli, B. Tüzün, H. Pişkin, G. Y. Atmaca, A. Erdoğmuş, M. N. Yarasir, J. Photochem. Photobiol., A. 2019, 373, 77.
- 59A. Günsel, E. Kırbaç, B. Tüzün, A. Erdoğmuş, A. T. Bilgiçli, M. N. Yarasir, J. Mol. Struct. 2019, 1180, 127.
- 60A. Günsel, A. Kobyaoğlu, A. T. Bilgiçli, B. Tüzün, B. Tosun, G. Arabaci, M. N. Yarasir, J. Mol. Struct. 2020, 1200, 127127.
- 61A. Günsel, A. T. Bilgiçli, H. Pişkin, B. Tüzün, N. Ç. Delibaş, M. N. Yarasir, B. Gündüz, J. Mol. Struct. 2019, 1193, 247.
- 62M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. A. Petersson, H. Nakatsuji, M. Caricato, X. Li, H. P. Hratchian, A. F. Izmaylov, J. Bloino, G. Zheng, J. L. Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J. A. Montgomery, J. E. Peralta, F. Ogliaro, M. Bearpark, J. J. Heyd, E. Brothers, K. N. Kudin, V. N. Staroverov, R. Kobayashi, J. Normand, K. Raghavachari, A. Rendell, J. C. Burant, S. S. Iyengar, J. Tomasi, M. Cossi, N. Rega, J. M. Millam, M. Klene, J. E. Knox, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, R. L. Martin, K. Morokuma, V. G. Zakrzewski, G. A. Voth, P. Salvador, J. J. Dannenberg, S. Dapprich, A. D. Daniels, O. Farkas, J. B. Foresman, J. V. Ortiz, J. Cioslowski, D. J. Fox, Gaussian 09, revision D.01, Gaussian Inc., Wallingford CT, 2009, 4, 2018.
- 63Schrödinger. Small-Molecule Drug Discovery Suite 2019-4.
- 64(a) Schrödinger Release 2019-4: Protein Preparation Wizard; Epik, Schrödinger, LLC, New York, NY, 2016; (b) Impact, Schrödinger, LLC, New York, NY, 2016; (c) Prime, Schrödinger, LLC, New York, NY, 2019.
- 65R. A. Friesner, R. B. Murphy, M. P. Repasky, L. L. Frye, J. R. Greenwood, T. A. Halgren, P. C. Sanschagrin, D. T. Mainz, J. Med. Chem. 2006, 49, 6177.
- 66G. M. Sastry, M. Adzhigirey, T. Day, R. Annabhimoju, W. Sherman, J. Comput.-Aided Mol. Des. 2013, 27, 221.
- 67R. Schrödinger, Release 2019-4: LigPrep, Schrödinger, LLC, New York, NY 2019.
- 68Q. Du, Y. Qian, X. Yao, W. Xue, J. Biomol. Struct. Dyn. 2020, 38, 625.
- 69Schrödinger, Release 2020-1: QikProp, Schrödinger, LLC, New York, NY 2020.